Fighting Until the End: How Baron & Budd Obtained a $916 Million Judgment Against Global Drug Manufacturers on Behalf of State of Hawai‘i
Baron & Budd proudly announced a $916,012,000 judgment against some of the world’s largest...
READ MORECities across the United States have been forced to bear staggering costs associated with the nationwide opioid epidemic. According to one study, municipalities have spent nearly $8 billion in lost tax revenue and costs associated with the criminal justice system – and that number will very likely rise. Public entities across the U.S. are joining with Baron & Budd in a fight to hold the makers of opioid drugs responsible for the role they’ve played in creating this national crisis.
Baron & Budd is representing the cities of Louisville, KY, Cincinnati and Birmingham, AL and many other public entities in lawsuits against pharmaceutical companies. These and other municipalities have been burdened with costs associated with law enforcement, education and addiction treatment. They are filing suit in order to cover not only expenses related to law enforcement, but also costs to help care for the children of parents addicted to opioids. Tragically, cities have also faced expenses related to the treatment of infants born with medical conditions related to their parents’ opioid use.
At Baron & Budd, we have a long history of success in prosecuting cases on behalf of public entities. In one case, we represented seven states in a case against pharmaceutical giant GlaxoSmithKline and were able to win a $177 million settlement for our clients.
Please get in touch with Baron & Budd if you represent a public entity that faces spiraling costs due to the nation’s opioid epidemic. Contact us online or call 866-320-4662 to learn more about how we may be able to help.